APA (7th ed.) Citation

ND, O., EC, W., LR, W., R, P., C, B., KA, E., . . . R, L. (2026). Treatment-Related Adverse Events and Health-Related Quality of Life Associated With Immune Checkpoint Inhibitor Treatment for Mucosal Head and Neck Squamous Cell Carcinoma: A Scoping Review. Head & neck. https://doi.org/10.1002/hed.70306

Chicago Style (17th ed.) Citation

ND, O'Donnell, et al. "Treatment-Related Adverse Events and Health-Related Quality of Life Associated With Immune Checkpoint Inhibitor Treatment for Mucosal Head and Neck Squamous Cell Carcinoma: A Scoping Review." Head & Neck 2026. https://doi.org/10.1002/hed.70306.

MLA (9th ed.) Citation

ND, O'Donnell, et al. "Treatment-Related Adverse Events and Health-Related Quality of Life Associated With Immune Checkpoint Inhibitor Treatment for Mucosal Head and Neck Squamous Cell Carcinoma: A Scoping Review." Head & Neck, 2026, https://doi.org/10.1002/hed.70306.